HER2-low and HER2-zero in Breast Cancer Between Prognosis, Prediction and Entity
July 16, 2024
PRESS RELEASE: On June 20, 2024, a new editorial was published in Oncotarget, entitled, “HER2-low and HER2-zero in breast cancer between prognosis, prediction and entity.” continue reading »